Name

MLN518

Alternate Names

CT 53518
CT-53518
CT53518

Abbreviations

None

Category

Chemotherapy

Subcategory

Cytostatic agent--receptor tyrosine kinase inhibitor

NSC Number

None

Primary Site

Leukemia

Histology

None

Remarks

Phase I AML Phase I AML FLT-3 receptor tyrosine kinase inhibitor. Millenium Pharmaceuticals.

Coding

This drug should be coded
Glossary